Eli Lilly | Deudores Comerciales



Trade Debtors Cambio Fecha
AbbVie USD 10.92B 553M 2024-12
Abbott USD 9.67B 2.74B 2025-03
ALKERMES USD 321.75M 72.97M 2025-03
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Baxter International USD 1.73B 53M 2024-12
Biogen USD 2B 127.7M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Indivior 272M 16M 2025-03
J&J USD 16.02B 1.18B 2025-03
Medtronic USD 6.52B 400M 2025-04
Merck USD 11.57B 452M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Novo Nordisk 86.37B 6.74B 2025-03
Perrigo USD 716.8M 30.6M 2025-03
Pfizer USD 14.74B 32M 2025-03
Prestige Brands USD 194.29M 27.02M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
Sanofi 10.63B 1.82B 2024-12
United Therapeutics USD 322M 42.7M 2025-03
Zoetis USD 1.36B 45M 2025-03



Eli Lilly Deudores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.